Chantix (varenicline) causes nausea in roughly one in three users, making it the most common side effect. Beyond nausea, the drug carries a range of other effects that span from mild sleep disruptions to serious neuropsychiatric and cardiovascular concerns. Understanding the full picture helps you weigh the benefits of quitting smoking against the risks of the medication itself.
One important note before diving in: Pfizer voluntarily recalled all lots of brand-name Chantix in September 2021 due to unacceptable levels of a cancer-linked impurity called N-nitroso-varenicline. As of 2022, the FDA confirmed that manufacturers can now supply generic varenicline with the impurity at or below acceptable safety limits. So while the brand name Chantix is no longer on shelves, generic varenicline is available.
Nausea and Digestive Issues
Nausea is by far the most frequently reported side effect. It tends to be worst in the first few weeks of treatment and often improves as your body adjusts. You can reduce it significantly by taking the pill after a meal with a full glass of water. Other gastrointestinal effects include constipation, gas, and vomiting, though these are less common than nausea.
Vivid Dreams and Sleep Problems
Unusual, vivid, or disturbing dreams are one of the side effects people notice most. Research suggests that varenicline doesn’t directly cause abnormal dream content. Instead, it appears to fragment sleep, causing lighter and more interrupted rest. Because you wake more frequently throughout the night, you’re more likely to remember your dreams, and those dreams can feel more intense or strange than usual. Insomnia and general difficulty sleeping are also reported. If vivid dreams become disruptive, some people find that taking the evening dose earlier in the day helps.
Neuropsychiatric Effects
This is the side effect category that has drawn the most attention and concern. After Chantix entered the market, reports began surfacing of users experiencing depression, agitation, aggression, hostility, suicidal thoughts, and even perceptual disturbances like hallucinations. These reports were significant enough that the FDA added a black box warning to the label, the most serious type of safety warning a drug can carry.
The FDA later removed that black box warning in 2016 after a large clinical trial found the neuropsychiatric risk was lower than initially feared, particularly in people without a history of mental health conditions. However, the warnings about these side effects remain on the label under “Warnings and Precautions.” The risk profile is serious enough that when the FDA evaluated varenicline for adolescent smokers (ages 12 to 16), it concluded the risks outweighed the benefits, in part because of these neuropsychiatric concerns.
What this means in practical terms: most people taking varenicline will not experience severe mood changes. But you should pay attention to shifts in your emotional state, especially in the first few weeks. New or worsening anxiety, feelings of hopelessness, unusual anger, or any thoughts of self-harm are signals to contact your prescriber promptly.
Cardiovascular Risks
The relationship between varenicline and heart problems has been studied extensively, with mixed results. One meta-analysis of 14 randomized controlled trials found a 72% higher odds of cardiovascular events (like heart attacks) in varenicline users compared to placebo. In absolute terms, though, the event rates were low: 1.06% in the varenicline group versus 0.82% in the placebo group. A later meta-analysis found no statistically significant increase in risk.
A separate trial specifically looking at patients who already had stable heart disease found a small excess of individual cardiovascular events, including non-fatal heart attacks and the need for procedures to restore blood flow to the heart. The differences were not statistically significant, but they were notable enough to warrant caution. If you have existing heart disease or risk factors, your prescriber will factor this into the decision.
Alcohol Interactions
Varenicline can change how your body responds to alcohol. Post-marketing reports have documented cases of reduced alcohol tolerance and unusual behavioral changes when the two are combined. Some people become more intoxicated than expected from their usual amount of alcohol, or behave uncharacteristically. Regulatory agencies in multiple countries have updated the drug’s safety information to reflect this. If you drink, it’s worth testing your tolerance carefully during treatment rather than assuming your usual limits still apply.
Other Reported Side Effects
Beyond the major categories above, varenicline has been associated with several additional effects:
- Headaches, which are common in the first week or two of treatment
- Sleepwalking (somnambulism), which is rare but has been reported frequently enough to be added to the label
- Seizures, which are uncommon but represent a serious risk
- Fatigue and drowsiness, particularly early in treatment
- Changes in taste, which some users describe as a metallic or unusual flavor
What Happens When You Stop
Stopping varenicline can trigger its own set of temporary symptoms. Some people experience a resurgence of nicotine cravings, irritability, depressed mood, and difficulty sleeping. These overlap significantly with standard nicotine withdrawal, which makes sense: the drug works by partially activating the same brain receptors that nicotine targets, so removing it can leave a gap. To minimize this rebound effect, prescribers often recommend tapering the dose gradually at the end of treatment rather than stopping abruptly. A standard course of varenicline lasts 12 weeks, though some people continue for an additional 12 weeks to reduce the chance of relapse.